Associate Director, R&D Finance
EmergencyMD, Gaithersburg, MD, United States
Altimmune (NASDAQ: ALT) is a late-stage clinical biopharmaceutical company focused on developing innovative peptide-based therapeutics for liver diseases. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of MASH and other indications. For more information, please visit www.altimmune.com.
Candidate Summary
Altimmune is seeking an Associate Director, R&D Finance, to serve as the primary finance lead for the MASH Phase 3 program, reporting to the Vice President, Finance. The candidate will be responsible for overseeing all finance, operational finance, and related finance activities for the MASH Phase 3 trial and related trials. This role will be the point of contact for the global CRO, the Controller, and the VP Head of Global MASH Program. This role requires a seasoned, strong background in financial management of large Phase 3 global clinical trials within the publicly listed biopharmaceutical industry.
Location: Hybrid
Key Responsibilities
MASH Clinical Finance & R&D Lead
Lead all MASH trials clinical trial budgeting, forecasting, and accrual analysis, including CRO costs incurred v invoiced, investigator grants, patient costs, and pass-through expenses.
Monitor clinical program costs versus plan, identifying risks, opportunities, and timing impacts.
Partner with Clinical Operations, Program Management, CMC, and Accounting to ensure accurate forecasting, spend visibility, and financial close alignment.
Review, evaluate, and support CMC, CRO, and clinical vendor agreements, including study budgets, change orders, and contract amendments, to ensure cost efficiency, appropriate risk sharing, and alignment with Finance & Accounting.
Provide financial diligence on clinical vendor proposals, assessing pricing structures, payment terms, scope assumptions, and financial risks in partnership with Legal, Program Management, and Clinical Operations.
Performance Management
Enhance financial transparency and decision support through operational and financial data analytics, reporting, and executive-ready materials.
Recommend actions to improve cost discipline, forecast accuracy, and resource utilization.
Process & Systems
Lead enhancements to FP&A processes, models, and planning tools as it relates to clinical trial finances.
Drive best practices in program-level forecasting, scenario planning, and financial reporting.
Partner with Finance and IT on Data Analytics, ERP, and FP&A system optimization.
Professional Experience and Qualifications
5+ years of FP&A late-stage clinical R&D finance experience in a public biopharma company
Experience managing finances for CRO spend
Track record of being a positive energy, excellent team player with an ability to work collaboratively and develop productive relationships with key stakeholders across the organization and externally
Experience building usable, easy-to-understand financial models in drug development companies
Ability to see connections between financials, data, and business drivers, and draw strategic and operational insights from the performance of the business
Advanced financial tools proficiency – NetSuite experience preferred
Strong oral and written presentation skills – ability to present to executive audiences
Exceptional attention to detail
Strong organizational skills and ability to prioritize work and multitask to meet deadlines
Outstanding time management skills and accountability.
Travel is required as needed.
Education
BA/BS in Accounting/Finance; CPA certification preferred.
Compensation
An attractive compensation package commensurate with the role.
#J-18808-Ljbffr
Candidate Summary
Altimmune is seeking an Associate Director, R&D Finance, to serve as the primary finance lead for the MASH Phase 3 program, reporting to the Vice President, Finance. The candidate will be responsible for overseeing all finance, operational finance, and related finance activities for the MASH Phase 3 trial and related trials. This role will be the point of contact for the global CRO, the Controller, and the VP Head of Global MASH Program. This role requires a seasoned, strong background in financial management of large Phase 3 global clinical trials within the publicly listed biopharmaceutical industry.
Location: Hybrid
Key Responsibilities
MASH Clinical Finance & R&D Lead
Lead all MASH trials clinical trial budgeting, forecasting, and accrual analysis, including CRO costs incurred v invoiced, investigator grants, patient costs, and pass-through expenses.
Monitor clinical program costs versus plan, identifying risks, opportunities, and timing impacts.
Partner with Clinical Operations, Program Management, CMC, and Accounting to ensure accurate forecasting, spend visibility, and financial close alignment.
Review, evaluate, and support CMC, CRO, and clinical vendor agreements, including study budgets, change orders, and contract amendments, to ensure cost efficiency, appropriate risk sharing, and alignment with Finance & Accounting.
Provide financial diligence on clinical vendor proposals, assessing pricing structures, payment terms, scope assumptions, and financial risks in partnership with Legal, Program Management, and Clinical Operations.
Performance Management
Enhance financial transparency and decision support through operational and financial data analytics, reporting, and executive-ready materials.
Recommend actions to improve cost discipline, forecast accuracy, and resource utilization.
Process & Systems
Lead enhancements to FP&A processes, models, and planning tools as it relates to clinical trial finances.
Drive best practices in program-level forecasting, scenario planning, and financial reporting.
Partner with Finance and IT on Data Analytics, ERP, and FP&A system optimization.
Professional Experience and Qualifications
5+ years of FP&A late-stage clinical R&D finance experience in a public biopharma company
Experience managing finances for CRO spend
Track record of being a positive energy, excellent team player with an ability to work collaboratively and develop productive relationships with key stakeholders across the organization and externally
Experience building usable, easy-to-understand financial models in drug development companies
Ability to see connections between financials, data, and business drivers, and draw strategic and operational insights from the performance of the business
Advanced financial tools proficiency – NetSuite experience preferred
Strong oral and written presentation skills – ability to present to executive audiences
Exceptional attention to detail
Strong organizational skills and ability to prioritize work and multitask to meet deadlines
Outstanding time management skills and accountability.
Travel is required as needed.
Education
BA/BS in Accounting/Finance; CPA certification preferred.
Compensation
An attractive compensation package commensurate with the role.
#J-18808-Ljbffr